Binge Eating Disorder: Symptoms, Diagnosis, and Treatment

According to DSM-5 criteria, a BED diagnosis requires recurring episodes of binge eating occurring at least once a week for a period of at least three months. The binge episode itself must meet two conditions simultaneously: consuming an objectively large amount of food in a short period, and a subjective sense of lacking control over eating during the episode — being unable to 'stop,' despite wanting to.

The key element distinguishing BED from occasional overeating is precisely the subjective distress tied to the episodes and their recurrence. Most people occasionally eat more than usual — at a holiday dinner, a party, or on an emotionally difficult day. That's not BED. A diagnosis requires a clear pattern, frequency, and pronounced psychological distress, not a single incident.

BED is the most common eating disorder — more common than anorexia nervosa and bulimia combined. Population studies using DSM-5 criteria have found prevalence rates around 5.6–6.9% in some studied populations, though earlier estimates based on the more restrictive DSM-IV criteria indicated lower figures (1.6% in women and 0.8% in men). Prevalence increases with body mass index (BMI), including significantly among people seeking weight-loss treatment or eligible for bariatric surgery.

Cognitive behavioral therapy (CBT) is the best-studied and most commonly recommended treatment for BED, shown to be more effective than purely pharmacological approaches in many comparative studies. CBT focuses on identifying and modifying the thoughts, beliefs, and behaviors that sustain the binge-eating cycle — including restrictive, 'all-or-nothing' thinking about food, which paradoxically often precedes and intensifies episodes of lost control.

CBT's effectiveness in treating eating disorders involving binge-eating episodes is confirmed across numerous studies, including analyses comparing treatment response and dropout rates among patients with bulimia and BED — with high rates of full symptom remission reported after completing therapy. CBT is typically delivered over 12–20 sessions, individually or in a group setting, and can be supplemented with mindfulness-based elements, which remain an area of ongoing clinical research.

Lisdexamfetamine is the only FDA-approved drug specifically for treating moderate-to-severe BED in adults, approved in 2015 based on two phase III trials involving a combined 724 patients. In both 12-week trials, lisdexamfetamine (at doses of 50–70 mg) significantly reduced the number of weekly binge-eating days compared with placebo — in one trial, the average reduction was 3.87 days in the drug group versus 2.51 days in the placebo group; in the other, 3.92 days versus 2.26 days in the placebo group.

BED is associated not only with the psychological distress tied to the episodes themselves, but also with an elevated risk of coexisting problems — depression, anxiety disorders, and, with a long-standing course, metabolic complications related to weight changes. Untreated BED tends to become entrenched as a chronic pattern, in which binge-eating episodes, shame, and attempts at restrictive dietary control feed off one another, creating a vicious cycle that's difficult to break without professional help.

Binge eating disorder is one of the most common, yet most misunderstood, mental health conditions — mistaken for a lack of willpower, dismissed as a 'habit,' or hidden by those experiencing it because of the deep shame that accompanies it. The good news is that BED is a disorder that responds well to treatment, and cognitive behavioral therapy offers a genuine chance at full symptom remission for a substantial share of patients.

If you recognize the pattern described here in yourself or someone close to you — recurring episodes of losing control over eating, accompanied by intense shame and distress — it's worth treating that as a signal to seek professional help, rather than something to be managed alone or to feel ashamed of.